Predictive Model for the Detection of Subclinical Atherosclerosis in HIV Patients on Antiretroviral Treatment

César Galvez-Barrón1, Sara Gamarra-Calvo2, Jose Ramon Blanco Ramos3

  • 1Research Area, Consorci Sanitari Alt Penedés-Garraf, Barcelona, Spain.

Current HIV Research
|June 10, 2025
PubMed

Insights

This study developed predictive models for early atherosclerosis detection in people living with HIV (PLHIV). Easily collected clinical variables identified patients at higher cardiovascular risk, aiding early intervention.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Medical Imaging

Background:

  • Patients living with HIV (PLHIV) exhibit increased cardiovascular risk.
  • Early detection of subclinical atherosclerosis is crucial for this population.
  • Existing risk assessment tools may not fully capture atherosclerosis risk in PLHIV.

Purpose of the Study:

  • To develop and validate predictive models for subclinical atherosclerosis in PLHIV.
  • To identify easily accessible clinical variables for atherosclerosis risk prediction.
  • To create a potential screening tool for early cardiovascular risk assessment in PLHIV.

Main Methods:

  • Cross-sectional observational study design.
  • Recruitment of PLHIV without established cardiovascular disease.
  • Development of predictive models using logistic regression and machine learning techniques.
  • Variables tested included sociodemographic, clinical, HIV-related, laboratory, and capillaroscopy data.
  • Internal validation using bootstrapping.

Main Results:

  • 19.8% of the 96 analyzed PLHIV had subclinical atherosclerosis.
  • Key predictors identified: hypertension, dyslipidaemia, protease inhibitors, triglycerides, fibrinogen, and alkaline phosphatase.
  • Logistic regression model achieved an AUC of 0.91 (0.80 after validation).
  • Machine learning models yielded AUCs between 0.73 and 0.86.

Conclusions:

  • The developed predictive models show relevant performance for subclinical atherosclerosis in PLHIV.
  • Models utilize easily accessible parameters, suggesting utility as a screening tool.
  • External validation in larger cohorts is recommended due to study limitations, particularly sample size.
Abstract

Related Concept Videos

Predicting Molecular Geometry02:27

Predicting Molecular Geometry

VSEPR Theory for Determination of Electron Pair Geometries
45.7K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
370
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.0K
Prediction Intervals01:03

Prediction Intervals

The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y. 
3.4K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
517
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
418